Four New Biotechs Launch to Combat MD, NASH, Parkinson's and More

cafead

Administrator
Staff member
  • cafead   Jun 23, 2021 at 11:02: PM
via There’s plenty of money on the move as venture capital firms and investors look to the future of biotech. Read on for today’s top Series A rounds.

Vita Therapeutics – The Baltimore, Maryland-based company announced an oversubscribed Series A financing worth $32 million. It was led by Cambrian Biopharma with participation from Kiwoom Bio, SCM Life Sciences, and Early Light Ventures.

article source
 

<